Use of Human Embryonic Stem Cell-Derived Cardiomyocyte Clusters to Assess Potential for Chronic Treatment With Compounds to Cause QT Prolongation

Pharmacology & Pharmacy
doi 10.4236/pp.2014.54044
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc,

Related search

Beat-To-Beat Variability in Field Potential Duration in Human Embryonic Stem Cell-Derived Cardiomyocyte Clusters for Assessment of Arrhythmogenic Risk, and a Case Study of Its Application

Pharmacology & Pharmacy
2014English

Deciphering the Β-Adrenergic Response in Human Embryonic Stem Cell-Derived-Cardiac Myocytes: Closer to Clinical Use?

British Journal of Pharmacology
Pharmacology
2008English

Immunogenicity of Human Embryonic Stem Cell-Derived Beta Cells

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Human Pluripotent Stem Cell-Derived Cardiomyocyte Based Models for Cardiotoxicity and Drug Discovery

Expert Opinion on Drug Safety
MedicinePharmacology
2016English

Human Embryonic Stem Cell (hESC)-derived NK Cells for Cancer Immunotherapy

Science-Business eXchange
2009English

Human Embryonic Stem Cell Lines Derived From Discarded Embryos

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2003English

Transplantation of Human Embryonic Stem Cell-Derived Endothelial Cells for Vascular Diseases

Journal of Cellular Biochemistry
BiochemistryCell BiologyMolecular Biology
2009English

QT Interval Prolongation Due to Metronidazole Administration

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
2011English

Human Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer

Cell
BiochemistryGeneticsMolecular Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy